Unlock structure-based drug design of challenging projects
For many biological targets of interest to pharma such as membrane proteins, structural information is difficult to obtain. The large size, complexity, and/or flexibility of these targets make them unsuitable for traditional structure determination techniques such as crystallography. Without structural insights to inform your drug design, you potentially miss out on discovering more effective drug candidates.
Cambridge, United Kingdom – 4th June 2020 - Congenica, a digital health company enabling rapid analysis of complex genomic data, has launched Congenica Prenatal™, a new application on its platform that helps to facilitate faster, more accurate and comprehensive molecular research into fetal anomalies.
Prenatal research into genetic anomalies helps support the management of pregnancy, labor and appropriate pre- and post-natal treatment. It can also assist with identifying the recurrence risk in future pregnancies.
Data will showcase capabilities of newly launched liquid biopsy assay for the detection of residual disease and recurrence
Research Triangle Park, NC, USA and Cambridge, UK, 04 June, 2020 -- Inivata, a leader in liquid biopsy, announces the presentation of new data supporting the Company’s newly launched RaDaR™ assay at the American Association for Cancer Research (AACR) Virtual Annual Meeting II, taking place on 22-24 June 2020.
The European based specialty pharmaceutical company, Ethypharm, collaborated with Reading Scientific Services Ltd (RSSL) to accelerate the manufacture and batch release of fentanyl injection; one of the critical medicines needed for the treatment of COVID-19 patients.
As a major supplier of essential medicines to the NHS, Ethypharm responded to requests from the Department of Health and Social Care (DHSC) for increased volumes of priority medicines by changing its production schedule to meet this urgent need.
Leaders in chemistry data management combine to deliver unified data resource for materials characterisation.
Two of the largest chemical data repositories have announced a new partnership which will allow greater utility and insights in the development of new drugs and materials.
An experienced public and private company Non-Executive Director, Peter has sat on over 30 boards during his career. He is currently a Non-Executive Director of Endomagnetics Ltd, a company improving cancer surgery outcomes; and the medical charity LifeArc which has assets significantly in excess of £1bn following the monetisation of the leading cancer drug Keytruda.
Recently, Santander’s John Carroll hosted our COVID-19 Webinar Series on digital health. Joined by sector and trade experts Timothy Johns MBA, Head of Digital Health at the Department for International Trade (DIT), Intralink’s Graham Barker and ChongYoon Kwon, Industrial Bank of Korea. They discussed what they’d learnt from the pandemic and the opportunities emerging for UK digital health companies. To listen go to: http://ms.spr.ly/6047T90Dv
As businesses look ahead to evolve their operations, Santander UK recently hosted a life science sector webinar with our partner, British Centres for Business - BCB UAE to look at the opportunities in the UAE and the acceleration of digital health in the region.
The downside of working with many C Suite Executives is that I also get to see the effects that stress and burnout can take on people.